Emergent BioSolutions
EBS
#7355
Rank
NZ$0.72 B
Marketcap
NZ$13.77
Share price
-3.00%
Change (1 day)
38.50%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): NZ$2.47

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is NZ$2.40. In 2024 the company made an earnings per share (EPS) of NZ-$6.19 an increase over its 2023 EPS that were of NZ-$25.36.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.47-139.95%
2024NZ-$6.19-75.61%
2023NZ-$25.36232.21%
2022NZ-$7.63-203.46%
2021NZ$7.38-25.09%
2020NZ$9.85445.28%
2019NZ$1.81-15.2%
2018NZ$2.13-35.9%
2017NZ$3.3269.57%
2016NZ$1.96-27.67%
2015NZ$2.7165.62%
2014NZ$1.6411.63%
2013NZ$1.4732.31%
2012NZ$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.32-3.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.45 418.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.42 167.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ-$5.52-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.72-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.76-339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.11-12.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel